These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 10368294)

  • 1. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for CDK6 activation by a virus-encoded cyclin.
    Schulze-Gahmen U; Kim SH
    Nat Struct Biol; 2002 Mar; 9(3):177-81. PubMed ID: 11828325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a gamma-herpesvirus cyclin-cdk complex.
    Card GL; Knowles P; Laman H; Jones N; McDonald NQ
    EMBO J; 2000 Jun; 19(12):2877-88. PubMed ID: 10856233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
    Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
    Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB; Gregory FJ; Stott FJ; Hara E; Peters G
    Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.
    Swanton C; Mann DJ; Fleckenstein B; Neipel F; Peters G; Jones N
    Nature; 1997 Nov; 390(6656):184-7. PubMed ID: 9367157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
    Parry D; Mahony D; Wills K; Lees E
    Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW; Montalvo E; Massagué J
    J Biol Chem; 1997 Oct; 272(41):25863-72. PubMed ID: 9325318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.
    Mann DJ; Child ES; Swanton C; Laman H; Jones N
    EMBO J; 1999 Feb; 18(3):654-63. PubMed ID: 9927425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
    Toyoshima H; Hunter T
    Cell; 1994 Jul; 78(1):67-74. PubMed ID: 8033213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
    Van Dross R; Yao S; Asad S; Westlake G; Mays DJ; Barquero L; Duell S; Pietenpol JA; Browning PJ
    J Natl Cancer Inst; 2005 May; 97(9):656-66. PubMed ID: 15870436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.
    Aprelikova O; Xiong Y; Liu ET
    J Biol Chem; 1995 Aug; 270(31):18195-7. PubMed ID: 7629134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Under arrest at atomic resolution.
    Morgan DO
    Nature; 1996 Jul; 382(6589):295-6. PubMed ID: 8684452
    [No Abstract]   [Full Text] [Related]  

  • 18. Low levels of cyclin D and nonfunctional Rb protein affect cdk6 association with cyclin-dependent kinase inhibitor p27(Kip1).
    Kwon TK; Park JW
    Biochem Biophys Res Commun; 2001 Jun; 284(1):106-11. PubMed ID: 11374878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
    Jeffrey PD; Tong L; Pavletich NP
    Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.